Drug Trial Radar · NCT02367313
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Last checked: Nov 19, 2026Latest source record: Jun 1, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
455
Actual
Start
Feb 2015
Primary completion
Dec 2016
Study completion Dec 2016
Sponsor
- Lead sponsor
- Biota Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Feb 20, 2015
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This Phase 2 protocol is designed to compare two dose levels of Vapendavir versus placebo. The objectives are to obtain safety and efficacy data in moderate to severe asthmatic patients, aged 18 to 75 years at risk of loss of asthma control due to presumptive Human Rhinovirus infection.
Conditions
- Asthma
Interventions
VapendavirDrug
Vapendavir 264 mg twice daily
VapendavirDrug
Vapendavir 528 mg twice daily
PlaceboDrug
Placebo twice daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Asthma Control Questionnaire-6 (ACQ-6)Time frame: Baseline (Day 1) to Study Day 14
Locations
62 sites in 6 countries. Site status is shown where the registry gives one.
Biota Investigational site
Birmingham, Alabama
Biota Investigational site
Flagstaff, Arizona
Biota Investigational site
Bakersfield, California
Biota Investigational site
Los Angeles, California
Biota Investigational site
Orange, California
Biota Investigational Site
San Jose, California
Biota Investigational site
Stockton, California
Biota Investigational site
Centennial, Colorado
Biota Investigational site
Denver, Colorado
Biota Investigational site
Hialeah, Florida
Biota Investigational site
New Port Richey, Florida
Biota Investigational site
Oviedo, Florida
Biota Investigation site
Palmetto Bay, Florida
Biota Investigational site
Tallahassee, Florida
Biota Investigational site
Twin Falls, Idaho
Biota Investigational site
Baltimore, Maryland
Biota Investigational site
St Louis, Missouri
Biota Investigational site
Bellevue, Nebraska
Biota investigational site
Las Vegas, Nevada
Biota Investigational site
Ocean City, New Jersey
Biota Investigational site
Albuquerque, New Mexico
Biota Investigational site
Rockville Centre, New York
Biota Investigational site
Raleigh, North Carolina
Biota Investigational site
Fargo, North Dakota
Biota Investigational site
Middleburg, Ohio
Biota Investigational site
Toledo, Ohio
Biota Investigation site
Oklahoma City, Oklahoma
Biota Investigational site
Medford, Oregon
Biota Investigational site
Portland, Oregon
Biota Investigational site
Warwick, Rhode Island
Biota Investigational site
Houston, Texas
Biota Investigational site
Seattle, Washington
Biota Investigational site
Greenfield, Wisconsin
Biota Investigational site
Rousse, Bulgaria
Biota Investigational site
Sofia, Bulgaria
Biota Investigational site
Sofia, Bulgaria
Biota Investigational site
Sofia, Bulgaria
Biota Investigational site
Sofia, Bulgaria
Biota Investigational site
Stara Zagora, Bulgaria
Biota Investigational site
Jindřichův Hradec, Czechia
Showing 40 of 62 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.